OrthoPediatrics KIDS Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OrthoPediatrics's additional paid-in capital?
- OrthoPediatrics (KIDS) reported additional paid-in capital of $626.01M in Q1 2026.
- How has OrthoPediatrics's additional paid-in capital changed year-over-year?
- OrthoPediatrics's additional paid-in capital increased by 3.5% year-over-year, from $604.99M to $626.01M.
- What is the long-term trend for OrthoPediatrics's additional paid-in capital?
- Over 5 years (2020 to 2025), OrthoPediatrics's additional paid-in capital has grown at a 9.9% compound annual growth rate (CAGR), from $388.62M to $622.33M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.